Mingteng International is a Cayman holding company for a Wuxi automotive-mold shop that spent the past year building a larger plant while the listed equity was repeatedly recapitalized. The operating story is a real manufacturer of casting dies for turbochargers, brakes, steering parts, and new-energy powertrains. The listed story is a Nasdaq Capital Market stub that already used a two-hundred-for-one consolidation and still trades just above the exchange bid floor.
The plant move is the operational event that has to justify the capital raise. Management completed a December relocation into a larger Wuxi workshop and framed a half-again increase in mold capacity, then deepened an existing relationship with a heavy-duty new-energy motor supplier. Revenue did grow into the low teens of millions last year. Gross margin, however, compressed into the low twenties, machining took a larger slice of the mix, and two customers still account for about two fifths of sales. Cash at year-end was thin relative to receivables, so the shop is funding a bigger factory from the public market rather than from internally generated cash.
The equity math is the binding constraint. An at-the-market program sold more than two hundred million pre-consolidation Class A shares for roughly $21 million of gross proceeds. June then brought two registered directs priced at $2 a share plus attached warrants. The share count now sits near eight million Class A shares against a market value under $8 million. The open question is whether the new floor space fills at prices that restore margin, or whether the next financing round arrives before the plant earns its keep.